Fighting resistant blood cancer cells

(BIOSS - Centre for Biological Signalling Studies) Around 20 percent of adults diagnosed with leukemia suffer from chronic myeloid leukemia (CML). The protein Gab2 works as an enhancer of cancer-causing signals and is often present in larger quantities in CML cells than in healthy cells. In two studies, Freiburg researchers have made new discoveries concerning the relationship between CML and Gab2 and drugs that can break a particular resistance to Gab2 in CML cells.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news